All participants who receive greater than 8 doses of VOR in the study will be required to enter a study cancer registry where they will be contacted once a year for 5 years after completion of their study participation. The registry is created because of genotoxic findings that were associated with the use of VOR. All participants will be monitored for development of future malignancies.